Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 250,000,000
    Countries
    Sector(s)
    Spain : € 250,000,000
    Health : € 250,000,000
    Signature date(s)
    11/05/2010 : € 250,000,000

    Summary sheet

    Release date
    17 June 2009
    Status
    Reference
    Signed | 11/05/2010
    20080760
    Project name
    Promoter - financial intermediary
    Sanidad Valencia 2009-2011

    Comunidad Valenciana

    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    Up to EUR 300 million.
    Estimated EUR 770 million.
    Location
    Sector(s)
    Description
    Objectives

    The ongoing health development and infrastructure plan of the Autonomous Region of Valencia involves the completion of a number of small health infrastructure investments, as well as a major investment in Valencia General University Hospital over the period between 2009 and 2012. The programme includes:

    • The creation of 43 new primary health care centres appropriately located across the Region and the rehabilitation and extension of 18 others;
    • The construction of five new small hospitals and the rehabilitation and extension of 11 others;
    • The replacement of the Valencia General University Hospital (Hospital La Fe), which is currently being rebuilt on a Greenfield site and expected to be complete in 2010.

    Located in a phasing-in region of Spain, the project is eligible under the convergence objective; as a health project, it responds to the Environmental priority objective under “sustainable communities” (health). As a result of the development of Valencia General University Hospital’s clinical education and research role, the project is also expected to respond to the Bank’s Knowledge Economy objective. The proportion of the project attributable to the Knowledge Economy objective will be explored during appraisal.

    Environmental aspects
    Procurement

    Health facilities are not specifically mentioned in the EIA Directive on Environmental Impact Assessment, though the project is covered by Annex II of the Directive in relation to urban development. The Bank’s services will verify the EIA screening decision of the Competent Authority during appraisal.

    Procurement procedures applied by the promoter are in compliance with EU Directives.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications